Atlas Trials

Efficacy (Induction of Response/Remission) and Safety Study in Patients With Moderate to Severe Crohn's Disease

Clinical trial NCT00206674 · COMPLETED

Trial details

NCT number
NCT00206674
Sponsor
Genzyme, a Sanofi Company
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Crohn Disease
Start date
2004-09-01
Primary completion
2006-06-01
Enrollment
286

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.